1 |
Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med 340;115-126, 1999
DOI
ScienceOn
|
2 |
Holness CL, Simmons DL: Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81;1607-1613, 1993
|
3 |
Bresnihan B: Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 26;717-719, 1999
|
4 |
Yanni G, Whelan A, Feighery C, Bresnihan B: Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 53;39-44, 1994
DOI
ScienceOn
|
5 |
Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, Chen SF, Hsieh SL, Nagata S, Ni J, Chen L: LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164;4105-4110, 2000
DOI
|
6 |
van Lent PL, Holthuysen AE, van den Bersselaar LA, van Rooijen N, Joosten LA, van de Loo FA, van de Putte LB,van den Berg WB: Phagocytic lining cells determine local expression of inflammation in type II collagen-induced arthritis. Arthritis Rheum 39;1545-1555, 1996
DOI
ScienceOn
|
7 |
Kolfschoten GM, Pradet-Balade B, Hahne M, Medema JP: TWE-PRIL; a fusion protein of TWEAK and APRIL. Biochem Pharmacol 66;1427-1432, 2003
DOI
ScienceOn
|
8 |
Kelly K, Manos E, Jensen G, Nadauld L, Jones DA: APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res 60;1021-1027, 2000
|
9 |
Shu HB, Hu WH, Johnson H: TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 65;680-683, 1999
DOI
|
10 |
Mackay F, Schneider P, Rennert P, Browning J: BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21;231-264, 2003
DOI
ScienceOn
|
11 |
Gorelik L, Gilbride K, Dobles M, Kalled SL, Zandman D, Scott ML: Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med 198;937-945, 2003
DOI
ScienceOn
|
12 |
Ng LG, Mackay CR, Mackay F: The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 42;763-772, 2005
DOI
ScienceOn
|
13 |
Schneider P: The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 17;282-289, 2005
DOI
ScienceOn
|
14 |
Jeon ST, Kim WJ, Lee SM, Lee MY, Park SB, Lee SH, Kim IS, Suk K, Choi BK, Choi EM, Kwon BS, Lee WH: Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunol Cell Biol 88;148-156, 2010
DOI
ScienceOn
|
15 |
Lee WH, Kim SH, Lee Y, Lee BB, Kwon B, Song H, Kwon BS, Park JE: Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 21;2004-2010, 2001
DOI
ScienceOn
|
16 |
Kim WJ, Lee WH: LIGHT is expressed in foam cells and involved in destabilization of atherosclerotic plaques through induction of matrix metalloproteinase-9 and IL-8. Immune Netw 4;116-122, 2004
DOI
|
17 |
Colli S, Eligini S, Lalli M, Camera M, Paoletti R, Tremoli E: Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol 17;265- 272, 1997
DOI
ScienceOn
|
18 |
Hahne M, Kataoka T, Schröter M, Hofmann K, Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE,Sordat B, Rimoldi D, Tschopp J: APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188;1185-1190, 1998
DOI
ScienceOn
|
19 |
Lesnik P, Rouis M, Skarlatos S, Kruth HS, Chapman MJ: Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages. Proc Natl Acad Sci U S A 89;10370-10374, 1992
DOI
ScienceOn
|
20 |
Pradet-Balade B, Medema JP, Lopez-Fraga M, Lozano JC, Kolfschoten GM, Picard A, Martínez-A C, Garcia-Sanz JA, Hahne M: An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J 21;5711-5720, 2002
DOI
ScienceOn
|
21 |
Libby P: Inflammation in atherosclerosis. Nature 420;868- 874, 2002
DOI
ScienceOn
|
22 |
Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT: Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 7;330-335, 1996
DOI
ScienceOn
|
23 |
Lee SM, Jeon ST, Kim WJ, Suk KH, Lee WH: Macrophages express membrane bound form of APRIL that can generate immunomodulatory signals. Immunology 131;350-356, 2010
DOI
ScienceOn
|
24 |
Mulherin D, Fitzgerald O, Bresnihan B: Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39;115-124, 1996
DOI
ScienceOn
|
25 |
Van Lent PL, Holthuysen AE, Van Rooijen N, Van De Putte LB, Van Den Berg WB: Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis. Ann Rheum Dis 57;408-413, 1998
DOI
ScienceOn
|
26 |
Dillon SR, Gross JA, Ansell SM, Novak AJ: An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5;235-246, 2006
DOI
ScienceOn
|